Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 0: 200302850, 2004; 10.1373/clinchem.2003.028506
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2003.028506v1
50/3/564    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by El-Hefnawy, T.
Right arrow Articles by Godfrey, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by El-Hefnawy, T.
Right arrow Articles by Godfrey, T. E.

Received on October 20, 2003
Accepted on December 12, 2003

Cancer Diagnostics

Characterization of Amplifiable, Circulating RNA in Plasma and Its Potential as a Tool for Cancer Diagnostics

Talal El-Hefnawy 1, Siva Raja 1, Lori Kelly 1, William L. Bigbee 2, John M. Kirkwood 2, James D. Luketich 3, Tony E. Godfrey 3*

1 Division of Thoracic Surgery, School of Medicine, University of Pittsburgh, Pittsburgh, PA
2 University of Pittsburgh Cancer Institute, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA
3 Division of Thoracic Surgery, School of Medicine, and University of Pittsburgh Cancer Institute, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA

* To whom correspondence should be addressed. E-mail: godfreyte{at}upmc.edu.

Background: Several recent reports have described the detection of circulating, cancer-related RNA molecules in serum or plasma from cancer patients, but little is known about the biology of this extracellular RNA. We aimed to determine how RNA is protected against degradation in serum, to optimize RNA isolation from large volumes of serum, and to test our optimized assays for serum-based cancer detection.

Methods: We used quantitative reverse transcription-PCR (QRT-PCR) analysis to investigate the isolation and biology of extracellular plasma RNA. We then examined the presence of amplifiable RNA transcripts in plasma and serum from controls and from patients with esophageal cancer and malignant melanoma.

Results: We found that extracellular RNA in plasma is highly degraded and can be isolated most efficiently by guanidinium-phenol extraction followed by precipitation. Extracellular RNA is stable in serum for up to 3 h but is destroyed immediately by addition of detergents. Extracellular RNA can be captured on 0.2 µm filters, allowing concentration of RNA from several milliliters of plasma. When we concentrated RNA from up to 4 mL of serum, detection of cancer-related transcripts in serum from cancer patients and controls was infrequent and inconsistent.

Conclusions: Extracellular RNA is most likely protected within protein or lipid vesicles, possibly apoptotic bodies, which can be disrupted by detergents. Despite optimizing many aspects of plasma RNA detection, we were unable to reproducibly detect cancer-related transcripts. Our data suggest that measurement of circulating RNA may not be a good approach to early cancer diagnosis.


The following articles in journals at HighWire Press have cited this article:


Home page
 J. Mol. Diagn.Home page
A. Anwar, G. Wan, K.-B. Chua, J. T. August, and H.-P. Too
Evaluation of Pre-Analytical Variables in the Quantification of Dengue Virus by Real-Time Polymerase Chain Reaction
J. Mol. Diagn., November 1, 2009; 11(6): 537 - 542.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Huang, H. Li, X. Ding, and C. Xiong
Presence and Characterization of Cell-Free Seminal RNA in Healthy Individuals: Implications for Noninvasive Disease Diagnosis and Gene Expression Studies of the Male Reproductive System
Clin. Chem., November 1, 2009; 55(11): 1967 - 1976.
[Abstract] [Full Text] [PDF]

Home page
 Lab AnimHome page
J A Krawiec, H Chen, S Alom-Ruiz, and M Jaye
Modified PAXgeneTM method allows for isolation of high-integrity total RNA from microlitre volumes of mouse whole blood
Lab Anim, October 1, 2009; 43(4): 394 - 398.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. J. Park, H. Zhou, D. Elashoff, B. S. Henson, D. A. Kastratovic, E. Abemayor, and D. T. Wong
Salivary microRNA: Discovery, Characterization, and Clinical Utility for Oral Cancer Detection
Clin. Cancer Res., September 1, 2009; 15(17): 5473 - 5477.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. S. Mitchell, R. K. Parkin, E. M. Kroh, B. R. Fritz, S. K. Wyman, E. L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K. C. O'Briant, A. Allen, et al.
Circulating microRNAs as stable blood-based markers for cancer detection
PNAS, July 29, 2008; 105(30): 10513 - 10518.
[Abstract] [Full Text] [PDF]

Home page
 Int J EpidemiolHome page
F Salway, P. Day, W. Ollier, and T. Peakman
Levels of 5' RNA tags in plasma and buffy coat from EDTA blood increase with time
Int. J. Epidemiol., April 1, 2008; 37(suppl_1): i11 - i15.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Rani, M. Clynes, and L. O'Driscoll
Detection of Amplifiable mRNA Extracellular to Insulin-Producing Cells: Potential for Predicting Beta Cell Mass and Function
Clin. Chem., November 1, 2007; 53(11): 1936 - 1944.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Collado, V. Garcia, J. M. Garcia, I. Alonso, L. Lombardia, R. Diaz-Uriarte, L. A. Lopez Fernandez, A. Zaballos, F. Bonilla, and M. Serrano
Genomic Profiling of Circulating Plasma RNA for the Analysis of Cancer
Clin. Chem., October 1, 2007; 53(10): 1860 - 1863.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
W. Sienel, I. Mecklenburg, S. Dango, P. Ehrhardt, A. Kirschbaum, B. Passlick, and K. Pantel
Detection of MAGE-A Transcripts in Bone Marrow Is an Independent Prognostic Factor in Operable Non-Small-Cell Lung Cancer
Clin. Cancer Res., July 1, 2007; 13(13): 3840 - 3847.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
N. J. Park, Y. Li, T. Yu, B. M.N. Brinkman, and D. T. Wong
Characterization of RNA in Saliva
Clin. Chem., June 1, 2006; 52(6): 988 - 994.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
Y. Li, D. Elashoff, M. Oh, U. Sinha, M. A.R. St John, X. Zhou, E. Abemayor, and D. T. Wong
Serum Circulating Human mRNA Profiling and Its Utility for Oral Cancer Detection
J. Clin. Oncol., April 10, 2006; 24(11): 1754 - 1760.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
X. T. Wang, W. Sienel, S. Eggeling, C. Ludwig, E. Stoelben, J. Mueller, C. A. Klein, and B. Passlick
Detection of disseminated tumor cells in mediastinoscopic lymph node biopsies and lymphadenectomy specimens of patients with NSCLC by quantitative RT-PCR
Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 26 - 32.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

Quantitative reduction in the RNP-contents of lymphocytes as a tool for early cancer diagnostics
Elissaveta B. Zvetkova, et al.
Clinical Chemistry Online, 3 Jul 2004 [Full text]
Quantitative reduction in TIL RNP-content in cancer as possible sign of RNAi
Elissaveta B. Zvetkova, et al.
Clinical Chemistry Online, 1 Aug 2005 [Full text]
Cancer-induced reduction in TIL cytoplasmic RNP - a sign of thymocyte apoptosis?
Elissaveta B. Zvetkova, et al.
Clinical Chemistry Online, 2 Oct 2006 [Full text]
Reduction in the RNP-contents of human T-lymphocytes in malignancies and viral diseases
Elissaveta B. Zvetkova
Clinical Chemistry Online, 26 Dec 2007 [Full text]

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by the American Association for Clinical Chemistry.